Latest Mammary ductal carcinoma Stories
By J. Hope Babowice You wanted to know Karina Alexis Casillas of Waukegan wanted to know: Do we have a cure for breast cancer? If you have a question you'd like Kids Ink to answer, write Kids Ink, care of the Daily Herald, 1795 N.
By Liz Szabo Christina Applegate's choice to have a double mastectomy puts her in the company of a growing number of women who are taking aggressive steps to avoid dying of breast cancer.
Breast cancer survivors may still have a substantial risk of disease recurrence five years after treatment, Houston researchers warn.
By Jane Oppermann It's a procedure that lasts no more than 20 minutes, delivers 5 to 10 seconds of discomfort and saves lives. But mammograms don't get high marks from many women, despite much effort to alleviate uneasiness or fear of pain.
By Lois M. Collins Deseret News In Tanzania, a woman might never be screened for breast cancer. If she is screened, it's because something seems to be wrong. There are no high-tech tools, it's a manual exam. And when cancer is found, it's likely well advanced.
By JUDY SIEGEL-ITZKOVICH You don't have to be Jewish to get breast cancer, but it "helps." Women in developed countries have a one-in-nine to one-in- seven lifetime risk of this disease, with about 90 percent of breast cancer developing spontaneously and not as a result of inheriting the well-known BRCA 1 or BRCA 2 genes.
By Adair, Jamie D Harvey, Kyle P; Mahmood, Ali; Caralis, James; Gordon, William; Yanish, Gregory Mucinous carcinoma of the breast, also known as colloid carcinoma, is a less common variant of breast cancer constituting less than five per cent of breast cancers.
According to a two-year study released on Monday in the January issue of the Archives of Surgery, breast surgery complications are more common than previously estimated. The study revealed that more than one in twenty patients who had breast surgery developed infections at incision sites.
Nancy Wong and Tracey King set out to investigate a boggling health phenomenon: American women are choosing overly aggressive treatments for breast cancer.
By Grabowski, Julia Salzstein, Sidney L; Sadler, Georgia R; Blair, Sarah L Malignant phyllodes tumor (MPT) is a rare breast malignancy. Because of the scarcity of the disease, there are no evidence-based treatment or follow-up guidelines established.